Ascend Gene & Cell Therapies

Aim higher with Ascend - Ascend

Founded 2021 · $130.0M raised

Founded
2021
Business Model
B2B
Total Funding
$130.0M
Last Round
$130.0M Venture RoundMar 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.

About

Since late 2024, Ascend has been aligned with ABL, Inc. Together they offer scalable support for specialty advanced therapeutic developers from research to commercialization, with United States and European locations. Ascend supports gene therapies, immunotherapies, oncolytics, and vaccines at any scale. The company became a CDMO after struggling to find partners for its own programs, and emphasizes chemistry, manufacturing, and controls expertise. Its capabilities include decades of custom biologics and vaccines support, more than 20 years of AAV development experience, next-generation analytics, regulatory acumen, and onsite fill-finish in multiple U.S. locations.

Summary

Ascend Gene & Cell Therapies is a Biotech company, founded in 2021. It has raised $130.0M in total across 1 round, most recently a $130.0M Venture Round in Mar 2023. Investors include DCVC (Data Collab), 4BIO Capital and Cathay Health.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundLaunch FundingMar 2023
$130.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ascend Gene & Cell Therapies on Indexed.vc
<a href="https://indexed.vc/companies/ascend-gene-cell-therapies"><img src="https://indexed.vc/api/badge/company/ascend-gene-cell-therapies" alt="Ascend Gene & Cell Therapies on Indexed.vc" width="260" height="76" /></a>